The RETATRUTIDE 40mg PEN delivers a high-concentration, ready-to-administer triple agonist peptide designed for advanced weight loss and metabolic health research. Retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously, making it one of the most potent next-generation peptides under investigation in obesity, insulin sensitivity, and energy regulation studies.
With a powerful 40mg dose, this pen is ideal for extended-duration trials, once-weekly protocols, or high-dose therapeutic modeling in controlled research settings.
